Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Pigmented Skin Lesions With MelaFind(R) System

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The lesion is pigmented (i.e., melanin, keratin, blood)~* Clinical management of the lesion by the examining dermatologist is either biopsy of the lesion in toto, or 3-month follow-up of the lesion~* The diameter of the pigmented area is between 2 and 22 millimeters~* The lesion is accessible to the MelaFind hand-held imaging device~* The patient, or a legally authorized representative, has consented to participate in the study and has signed the Informed Consent Form~Exclusion Criteria:~* The patient has a known allergy to isopropyl alcohol~* The lesion has been previously biopsied, excised, or traumatized~* The skin is not intact (e.g., open sores, ulcers, bleeding)~* The lesion is within 1 cm of the eye~* The lesion is on mucosal surfaces (e.g., lips, genitals)~* The lesion is on palmar hands~* The lesion is on plantar feet~* The lesion is on or under nails~* The lesion is located on or in an area of visible scarring~* The lesion contains foreign matter (e.g., tattoo, splinter, marker)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Biopsied Pigmented Skin Lesions (Type: OTHER): Pigmented skin lesions for which clinical management was prospectively determined to be biopsy of the lesion in toto

Based on this trial design, predict the completion outcome and termination type (if applicable).